FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biochemistry, particularly to an immunity inducing agent containing an active ingredient presented by an effective amount of at least one polypeptide possessing immunity inducing activity consisting in inducing CD8+ cytotoxic T-cells able to destruct tumour cells expressing human CAPRIN-1 polypeptide, and specified in the following polypeptides (a), (b) and (c), or an effective amount of a recombinant vector containing a polynucleotide coding such polypeptide and able to express such polypeptide in vivo: (a) a polypeptide of any amino acid sequence among SEQ ID NO: 43-76 sequence list; (b) a polypeptide 85% or more identical to the polypeptide (a) sequence (a); and (c) a polypeptide with 8-12 amino acids containing the polypeptides (a) or (b). The invention refers to a method for inducing the immunity using the above agent.
EFFECT: invention enables extending the range of products for inducing the immunity.
10 cl, 5 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNITY INDUCING AGENT | 2013 |
|
RU2639518C2 |
| IMMUNITY-INDUCING AGENT | 2012 |
|
RU2634862C2 |
| IMMUNITY-INDUCING MEANS | 2012 |
|
RU2614386C2 |
| MEDICATION FOR IMMUNITY INDUCTION AND METHOD OF MALIGNANT TUMOUR IDENTIFICATION | 2009 |
|
RU2519675C2 |
| CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING SAME | 2009 |
|
RU2502740C2 |
| CDCA1 PEPTIDE AND PHARMACEUTICAL DRUG CONTAINING IT | 2008 |
|
RU2486195C2 |
| IMP-3 OLIGOPEPTIDES AND VACCINES CONTAINING THEREOF | 2010 |
|
RU2550695C2 |
| PEPTIDE VACCINES FOR CANCER EXPRESSING MPHOSPH1 OR DEPDC1 POLYPEPTIDES | 2007 |
|
RU2469044C2 |
| PHARMACEUTICAL, CONTAINING EPITOPE PEPTIDES HIG2 AND URLC10, FOR CANCER TREATMENT, METHODS AND MEANS FOR INDUCTION OF ANTIGEN-PRESENTING CELL AND CYTOTOXIC T-LYMPHOCYTE (CTL), ANTIGEN-PRESENTING CELL AND CTL, OBTAINED THEREOF, METHOD AND MEANS OF IMMUNE ANTI-CANCER RESPONSE | 2009 |
|
RU2529373C2 |
| HJURP PEPTIDES AND VACCINES CONTAINING THEM | 2011 |
|
RU2570560C2 |
